Find disease awareness content and relevant supporting materials
FDA approves Kedrab [rabies immune globulin (Human)]for passive, transient post-exposure prophylaxis of rabies infection.- Kedrion Biopharma + Kamada Ltd.
Kedrion Biopharma and Kamada Ltd. two leading human-derived protein therapeutics companies, announced that Kedrab [rabies immune globulin (Human)] has received...
Human Rabies Immunoglobulin
Post-exposure prophylaxis of rabies infection in persons after exposure to scratches, bites or other injuries including mucous membrane contamination with infectious tissue, such as saliva, caused by a suspected rabid animal. Human rabies immunoglobulin must always be used in combination with a rabies vaccine.
Rabipur pre-filled syringe
Rabipur is indicated for active immunization against rabies in individuals of all ages. See Sections 4.2 and 5.1 for detailed information about pre- and post-exposure prophylaxis. Rabipur should be used in accordance with official recommendations.
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-l
In the COMBI-v trial, patients with previously untreated BRAF Val600Glu or Val600Lys mutant unresectable or metastatic melanoma who were treated with the combination of dabrafenib and trametinib...